CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Design, Contract and Testing Revenue	$ 35,165	$ 32,000
Operating Costs and Expenses
Amortization of patents and proprietary technology	23,741	25,585
Cost of revenue	1,344	2,827
Administrative and marketing expense	177,420	161,707
Research and development expense	80,059	66,420
Total Operating Costs and Expenses	282,564	256,539
Other Income and Expenses
Interest expense	(223,891)	(141,538)
Interest income	$ 1,915	15
Gain on conversion of notes		55,661
Loss on extinguishment of debt		(168,286)
Net Other Income (Expense)	$ (221,976)	(254,148)
Net Loss	$ (469,375)	$ (478,687)
Basic and Diluted Loss per Common Share	$ (0.01)	$ (0.01)
Basic and Diluted Weighted Average Common Shares Outstanding	71,627,114	57,864,114